Reaction Details Report a problem with these data
Target
Bromodomain-containing protein 4 [44-164]
Ligand
BDBM425421
Substrate
n/a
Meas. Tech.
Alphascreen Binding Assay
IC50
<1000±n/a nM
Citation
 Zhang, J; Buell, J; Chan, K; Ibrahim, PN; Lin, J; Pham, P; Shi, S; Spevak, W; Wu, G; Wu, J Heterocyclic compounds and uses thereof US Patent  US10519177 Publication Date 12/31/2019 
Target
Name:
Bromodomain-containing protein 4 [44-164]
Synonyms:
BRD4 | BRD4_HUMAN | Bromodomain-containing protein 4 (aa 44-164) | HUNK1
Type:
Enzyme Catalytic Domain
Mol. Mass.:
14412.06
Organism:
Homo sapiens (Human)
Description:
BRD4-BD1 (44-164)
Residue:
121
Sequence:
NPPPPETSNPNKPKRQTNQLQYLLRVVLKTLWKHQFAWPFQQPVDAVKLNLPDYYKIIKTPMDMGTIKKRLENNYYWNAQECIQDFNTMFTNCYIYNKPGDDIVLMAEALEKLFLQKINEL
  
Inhibitor
Name:
BDBM425421
Synonyms:
4-[1-benzyl-3-[1- (difluoromethyl)pyrazol-4- yl]pyrrolo[3,2-b]pyridin-6-yl]-3,5- dimethyl-isoxazole | US10519177, Compound P-0326
Type:
Small organic molecule
Emp. Form.:
C24H20F2N4O
Mol. Mass.:
418.4386
SMILES:
Cc1noc(C)c1-c1cnc2c(cn(Cc3ccccc3)c2c1)-c1ccn(c1)C(F)F
Structure:
Search PDB for entries with ligand similarity: